Perioperative Outcomes of Minimally Invasive Esophagectomy After Neoadjuvant Immunotherapy for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma

BACKGROUND: Immunotherapy has become a pillar of advanced solid tumors treatment. Patients are more likely to benefit from neoadjuvant immunotherapy compared with traditional neoadjuvant therapy. However, the safety and efficacy of neoadjuvant immunotherapy for the treatment of locally advanced, sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Jiahan, Guo, Minzhang, Yang, Yushang, Liu, Yilin, Hu, Weipeng, Shang, Qixin, Li, Chuan, Xia, Liang, Wang, Yun, Wang, Wenping, Tian, Dong, Yuan, Yong, Hu, Yang, Chen, Longqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965698/
https://www.ncbi.nlm.nih.gov/pubmed/35371089
http://dx.doi.org/10.3389/fimmu.2022.848881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965698/
https://www.ncbi.nlm.nih.gov/pubmed/35371089
http://dx.doi.org/10.3389/fimmu.2022.848881

Ejemplares similares